Anti-Siglec-15 monoclonal antibody NC-318 well tolerated and active in first-in-human study Nov. 21, 2019
Adenosine A2A receptor antagonist DZD-2269 overcomes adenosine-induced immunosuppression Nov. 20, 2019
Preliminary clinical data on CRISPR/Cas9 gene-editing therapy CTX-001 in severe hemoglobinopathies Nov. 20, 2019
RSS